Rebates, Discounts, And Antitrust: HHS Thinks Law Is On Its Side

One concern raised ahead of HHS proposal to eliminate the “Safe Harbor” permitting prescription drug rebates is that the alternative – up-front discounts – may run afoul of antitrust law. HHS, however, is advising stakeholders to review the law more carefully.